Work

Fatty liver disease as a risk factor for impaired hemostasis in patients with COVID-19

Year: 2025

Type: article

Abstract: The effect of fatty liver disease (FLD) on hemostasis disorders in COVID-19 was studied. Hemostasis disorders were detected in 30% of COVID-19 deaths. FLD was more common (19%) in COVID-19 deaths with hemostasis disorders than in COVID-19 deaths without hemostasis disorders (12%), p = 0.019. Thus, the study results showed statistical significance of hemostasis pathology in the COVID-19 mortality structure.

Source: Yakut Medical Journal

DOI: 10.25789/ymj.2025.89.25

Authors: O. V. Tirikova, D. V. Sudyarova, N. B. Elmurodova

Institution: Irkutsk State Medical University

Language: English

Topic: COVID-19 Clinical Research Studies

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4408769263

FWCI:

Cites: 13

Cited by:

Related to: 10